Recent advances in tyrosine kinase inhibitors

被引:40
|
作者
Fry, DW
机构
[1] Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company Ann, Arbor
关键词
D O I
10.1016/S0065-7743(08)60455-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:151 / 160
页数:10
相关论文
共 50 条
  • [1] Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
    Zhao, Qi
    Wu, Zhanxuan E.
    Li, Bin
    Li, Fei
    [J]. PHARMACOLOGY & THERAPEUTICS, 2022, 237
  • [2] Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents
    Guo, Ting
    Ma, Shutao
    [J]. CHEMMEDCHEM, 2021, 16 (04) : 600 - 620
  • [3] Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors
    C Lemos
    G Jansen
    G J Peters
    [J]. British Journal of Cancer, 2008, 98 : 857 - 862
  • [4] Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer
    Ferrari, Silvia Martina
    Patrizio, Armando
    Stoppini, Giulio
    Elia, Giusy
    Ragusa, Francesca
    Balestri, Eugenia
    Botrini, Chiara
    Rugani, Licia
    Barozzi, Emilio
    Mazzi, Valeria
    La Motta, Concettina
    Antonelli, Alessandro
    Fallahi, Poupak
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (12) : 1667 - 1676
  • [5] Drug transporters: Recent advances concerning BCRP and tyrosine kinase inhibitors
    Lemos, C.
    Jansen, G.
    Peters, G. J.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (05) : 857 - 862
  • [6] Inhibiting signal transduction: Recent advances in the development of receptor tyrosine kinase and Ras inhibitors
    Hao, D
    Rowinsky, EK
    [J]. CANCER INVESTIGATION, 2002, 20 (03) : 387 - 404
  • [7] Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy
    Pan, Qingqing
    Lu, Yao
    Xie, Li
    Wu, Di
    Liu, Rong
    Gao, Wenxia
    Luo, Kui
    He, Bin
    Pu, Yuji
    [J]. MOLECULAR PHARMACEUTICS, 2023, : 829 - 852
  • [8] Recent advances in irreversible kinase inhibitors
    Gilbert, Adam M.
    [J]. PHARMACEUTICAL PATENT ANALYST, 2014, 3 (04) : 375 - 386
  • [9] Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
    Qin, Shuang
    Li, Anping
    Yi, Ming
    Yu, Shengnan
    Zhang, Mingsheng
    Wu, Kongming
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [10] Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
    Shuang Qin
    Anping Li
    Ming Yi
    Shengnan Yu
    Mingsheng Zhang
    Kongming Wu
    [J]. Journal of Hematology & Oncology, 12